SARS-CoV-2 Analysis Results (GEO series: GSE147507)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
NFATC2
|
ENSG00000101096.15 | nuclear factor of activated T cells 2 |
NFATC3
|
ENSG00000072736.14 | nuclear factor of activated T cells 3 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
NFATC2 | hg19_v2_chr20_-_50159198_50159299 | -0.42 | 6.6e-02 | Click! |
NFATC3 | hg19_v2_chr16_+_68119764_68119868 | 0.38 | 9.8e-02 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr1_+_209602771 | 4.14 |
ENST00000440276.1
|
MIR205HG
|
MIR205 host gene (non-protein coding) |
chr1_-_153538011 | 3.75 |
ENST00000368707.4
|
S100A2
|
S100 calcium binding protein A2 |
chr12_-_50616122 | 3.25 |
ENST00000552823.1
ENST00000552909.1 |
LIMA1
|
LIM domain and actin binding 1 |
chr1_+_209602609 | 3.21 |
ENST00000458250.1
|
MIR205HG
|
MIR205 host gene (non-protein coding) |
chr1_+_46640750 | 3.01 |
ENST00000372003.1
|
TSPAN1
|
tetraspanin 1 |
chr18_+_29027696 | 2.93 |
ENST00000257189.4
|
DSG3
|
desmoglein 3 |
chr12_-_50616382 | 2.48 |
ENST00000552783.1
|
LIMA1
|
LIM domain and actin binding 1 |
chr7_-_41742697 | 2.22 |
ENST00000242208.4
|
INHBA
|
inhibin, beta A |
chr16_-_28192360 | 2.19 |
ENST00000570033.1
|
XPO6
|
exportin 6 |
chr17_-_39093672 | 2.10 |
ENST00000209718.3
ENST00000436344.3 ENST00000485751.1 |
KRT23
|
keratin 23 (histone deacetylase inducible) |
chr3_+_99357319 | 1.83 |
ENST00000452013.1
ENST00000261037.3 ENST00000273342.4 |
COL8A1
|
collagen, type VIII, alpha 1 |
chr15_+_93443419 | 1.76 |
ENST00000557381.1
ENST00000420239.2 |
CHD2
|
chromodomain helicase DNA binding protein 2 |
chr17_+_74372662 | 1.76 |
ENST00000591651.1
ENST00000545180.1 |
SPHK1
|
sphingosine kinase 1 |
chr3_-_112360116 | 1.75 |
ENST00000206423.3
ENST00000439685.2 |
CCDC80
|
coiled-coil domain containing 80 |
chr15_+_43885252 | 1.75 |
ENST00000453782.1
ENST00000300283.6 ENST00000437924.1 ENST00000450086.2 |
CKMT1B
|
creatine kinase, mitochondrial 1B |
chr8_+_102504979 | 1.74 |
ENST00000395927.1
|
GRHL2
|
grainyhead-like 2 (Drosophila) |
chr5_-_78808617 | 1.71 |
ENST00000282260.6
ENST00000508576.1 ENST00000535690.1 |
HOMER1
|
homer homolog 1 (Drosophila) |
chr14_+_24837226 | 1.67 |
ENST00000554050.1
ENST00000554903.1 ENST00000554779.1 ENST00000250373.4 ENST00000553708.1 |
NFATC4
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 4 |
chr15_+_43985084 | 1.66 |
ENST00000434505.1
ENST00000411750.1 |
CKMT1A
|
creatine kinase, mitochondrial 1A |
chr11_+_34654011 | 1.65 |
ENST00000531794.1
|
EHF
|
ets homologous factor |
chr14_+_65170820 | 1.59 |
ENST00000555982.1
|
PLEKHG3
|
pleckstrin homology domain containing, family G (with RhoGef domain) member 3 |
chr17_+_44701402 | 1.56 |
ENST00000575068.1
|
NSF
|
N-ethylmaleimide-sensitive factor |
chr6_+_106959718 | 1.56 |
ENST00000369066.3
|
AIM1
|
absent in melanoma 1 |
chr1_+_24975417 | 1.53 |
ENST00000537199.1
|
SRRM1
|
serine/arginine repetitive matrix 1 |
chr11_-_119187826 | 1.49 |
ENST00000264036.4
|
MCAM
|
melanoma cell adhesion molecule |
chr4_-_41216492 | 1.49 |
ENST00000503503.1
ENST00000509446.1 ENST00000503264.1 ENST00000508707.1 ENST00000508593.1 |
APBB2
|
amyloid beta (A4) precursor protein-binding, family B, member 2 |
chr11_+_101983176 | 1.44 |
ENST00000524575.1
|
YAP1
|
Yes-associated protein 1 |
chr4_+_26322409 | 1.37 |
ENST00000514807.1
ENST00000348160.4 ENST00000509158.1 ENST00000355476.3 |
RBPJ
|
recombination signal binding protein for immunoglobulin kappa J region |
chr6_+_144665237 | 1.35 |
ENST00000421035.2
|
UTRN
|
utrophin |
chr1_-_156675564 | 1.31 |
ENST00000368220.1
|
CRABP2
|
cellular retinoic acid binding protein 2 |
chr1_-_156675535 | 1.31 |
ENST00000368221.1
|
CRABP2
|
cellular retinoic acid binding protein 2 |
chr16_+_55600580 | 1.30 |
ENST00000457326.2
|
CAPNS2
|
calpain, small subunit 2 |
chr11_-_123065989 | 1.29 |
ENST00000448775.2
|
CLMP
|
CXADR-like membrane protein |
chr5_-_124081008 | 1.29 |
ENST00000306315.5
|
ZNF608
|
zinc finger protein 608 |
chr3_+_152017924 | 1.29 |
ENST00000465907.2
ENST00000492948.1 ENST00000485509.1 ENST00000464596.1 |
MBNL1
|
muscleblind-like splicing regulator 1 |
chr4_+_100737954 | 1.26 |
ENST00000296414.7
ENST00000512369.1 |
DAPP1
|
dual adaptor of phosphotyrosine and 3-phosphoinositides |
chr1_-_207206092 | 1.26 |
ENST00000359470.5
ENST00000461135.2 |
C1orf116
|
chromosome 1 open reading frame 116 |
chr2_-_163099885 | 1.22 |
ENST00000443424.1
|
FAP
|
fibroblast activation protein, alpha |
chr5_+_148960931 | 1.20 |
ENST00000333677.6
|
ARHGEF37
|
Rho guanine nucleotide exchange factor (GEF) 37 |
chr2_-_216003127 | 1.19 |
ENST00000412081.1
ENST00000272895.7 |
ABCA12
|
ATP-binding cassette, sub-family A (ABC1), member 12 |
chr1_-_156675368 | 1.17 |
ENST00000368222.3
|
CRABP2
|
cellular retinoic acid binding protein 2 |
chr2_-_163100045 | 1.14 |
ENST00000188790.4
|
FAP
|
fibroblast activation protein, alpha |
chr17_+_36584662 | 1.14 |
ENST00000431231.2
ENST00000437668.3 |
ARHGAP23
|
Rho GTPase activating protein 23 |
chr11_+_34663913 | 1.13 |
ENST00000532302.1
|
EHF
|
ets homologous factor |
chr3_-_18480260 | 1.11 |
ENST00000454909.2
|
SATB1
|
SATB homeobox 1 |
chr19_+_13134772 | 1.08 |
ENST00000587760.1
ENST00000585575.1 |
NFIX
|
nuclear factor I/X (CCAAT-binding transcription factor) |
chr6_+_150464155 | 1.07 |
ENST00000361131.4
|
PPP1R14C
|
protein phosphatase 1, regulatory (inhibitor) subunit 14C |
chr14_-_23623577 | 1.03 |
ENST00000422941.2
ENST00000453702.1 |
SLC7A8
|
solute carrier family 7 (amino acid transporter light chain, L system), member 8 |
chr3_-_71353892 | 1.03 |
ENST00000484350.1
|
FOXP1
|
forkhead box P1 |
chr2_-_113594279 | 1.02 |
ENST00000416750.1
ENST00000418817.1 ENST00000263341.2 |
IL1B
|
interleukin 1, beta |
chr3_-_56809534 | 0.98 |
ENST00000497267.1
|
ARHGEF3
|
Rho guanine nucleotide exchange factor (GEF) 3 |
chr5_+_173316341 | 0.97 |
ENST00000520867.1
ENST00000334035.5 |
CPEB4
|
cytoplasmic polyadenylation element binding protein 4 |
chr11_+_34664014 | 0.95 |
ENST00000527935.1
|
EHF
|
ets homologous factor |
chr6_+_15246501 | 0.94 |
ENST00000341776.2
|
JARID2
|
jumonji, AT rich interactive domain 2 |
chr5_+_49962772 | 0.92 |
ENST00000281631.5
ENST00000513738.1 ENST00000503665.1 ENST00000514067.2 ENST00000503046.1 |
PARP8
|
poly (ADP-ribose) polymerase family, member 8 |
chr3_+_111578131 | 0.91 |
ENST00000498699.1
|
PHLDB2
|
pleckstrin homology-like domain, family B, member 2 |
chr13_-_99667960 | 0.90 |
ENST00000448493.2
|
DOCK9
|
dedicator of cytokinesis 9 |
chr18_+_55888767 | 0.89 |
ENST00000431212.2
ENST00000586268.1 ENST00000587190.1 |
NEDD4L
|
neural precursor cell expressed, developmentally down-regulated 4-like, E3 ubiquitin protein ligase |
chr20_+_44637526 | 0.89 |
ENST00000372330.3
|
MMP9
|
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) |
chr6_+_138188378 | 0.88 |
ENST00000420009.1
|
TNFAIP3
|
tumor necrosis factor, alpha-induced protein 3 |
chr7_-_20256965 | 0.86 |
ENST00000400331.5
ENST00000332878.4 |
MACC1
|
metastasis associated in colon cancer 1 |
chr5_+_49963239 | 0.85 |
ENST00000505554.1
|
PARP8
|
poly (ADP-ribose) polymerase family, member 8 |
chr14_+_72052983 | 0.84 |
ENST00000358550.2
|
SIPA1L1
|
signal-induced proliferation-associated 1 like 1 |
chr8_+_128748466 | 0.84 |
ENST00000524013.1
ENST00000520751.1 |
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog |
chr12_-_6484715 | 0.83 |
ENST00000228916.2
|
SCNN1A
|
sodium channel, non-voltage-gated 1 alpha subunit |
chr6_+_106534192 | 0.83 |
ENST00000369091.2
ENST00000369096.4 |
PRDM1
|
PR domain containing 1, with ZNF domain |
chr1_+_150254936 | 0.83 |
ENST00000447007.1
ENST00000369095.1 ENST00000369094.1 |
C1orf51
|
chromosome 1 open reading frame 51 |
chr6_+_158733692 | 0.83 |
ENST00000367094.2
ENST00000367097.3 |
TULP4
|
tubby like protein 4 |
chrX_+_22056165 | 0.82 |
ENST00000535894.1
|
PHEX
|
phosphate regulating endopeptidase homolog, X-linked |
chr4_-_41216473 | 0.82 |
ENST00000513140.1
|
APBB2
|
amyloid beta (A4) precursor protein-binding, family B, member 2 |
chr3_+_111578027 | 0.80 |
ENST00000431670.2
ENST00000412622.1 |
PHLDB2
|
pleckstrin homology-like domain, family B, member 2 |
chrX_+_56259316 | 0.79 |
ENST00000468660.1
|
KLF8
|
Kruppel-like factor 8 |
chr14_+_90864504 | 0.79 |
ENST00000544280.2
|
CALM1
|
calmodulin 1 (phosphorylase kinase, delta) |
chr17_+_7341586 | 0.78 |
ENST00000575235.1
|
FGF11
|
fibroblast growth factor 11 |
chr3_-_167813132 | 0.77 |
ENST00000309027.4
|
GOLIM4
|
golgi integral membrane protein 4 |
chr4_-_100356291 | 0.77 |
ENST00000476959.1
ENST00000482593.1 |
ADH7
|
alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide |
chr1_+_209941942 | 0.77 |
ENST00000487271.1
ENST00000477431.1 |
TRAF3IP3
|
TRAF3 interacting protein 3 |
chr11_-_57089774 | 0.75 |
ENST00000527207.1
|
TNKS1BP1
|
tankyrase 1 binding protein 1, 182kDa |
chr3_-_71632894 | 0.74 |
ENST00000493089.1
|
FOXP1
|
forkhead box P1 |
chr6_-_112081113 | 0.74 |
ENST00000517419.1
|
FYN
|
FYN oncogene related to SRC, FGR, YES |
chr5_+_150591678 | 0.73 |
ENST00000523466.1
|
GM2A
|
GM2 ganglioside activator |
chr4_-_140477353 | 0.73 |
ENST00000406354.1
ENST00000506866.2 |
SETD7
|
SET domain containing (lysine methyltransferase) 7 |
chr17_+_7387677 | 0.73 |
ENST00000322644.6
|
POLR2A
|
polymerase (RNA) II (DNA directed) polypeptide A, 220kDa |
chr1_+_38022513 | 0.73 |
ENST00000296218.7
|
DNALI1
|
dynein, axonemal, light intermediate chain 1 |
chr7_+_44663908 | 0.72 |
ENST00000543843.1
|
OGDH
|
oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) |
chr1_+_44401479 | 0.71 |
ENST00000438616.3
|
ARTN
|
artemin |
chr1_-_161337662 | 0.71 |
ENST00000367974.1
|
C1orf192
|
chromosome 1 open reading frame 192 |
chr14_+_65171099 | 0.71 |
ENST00000247226.7
|
PLEKHG3
|
pleckstrin homology domain containing, family G (with RhoGef domain) member 3 |
chr4_-_87770416 | 0.71 |
ENST00000273905.6
|
SLC10A6
|
solute carrier family 10 (sodium/bile acid cotransporter), member 6 |
chr6_-_47010061 | 0.70 |
ENST00000371253.2
|
GPR110
|
G protein-coupled receptor 110 |
chr11_+_131240373 | 0.70 |
ENST00000374791.3
ENST00000436745.1 |
NTM
|
neurotrimin |
chr13_-_86373536 | 0.69 |
ENST00000400286.2
|
SLITRK6
|
SLIT and NTRK-like family, member 6 |
chr9_+_124062071 | 0.69 |
ENST00000373818.4
|
GSN
|
gelsolin |
chr14_+_65171315 | 0.69 |
ENST00000394691.1
|
PLEKHG3
|
pleckstrin homology domain containing, family G (with RhoGef domain) member 3 |
chr4_+_26322185 | 0.67 |
ENST00000361572.6
|
RBPJ
|
recombination signal binding protein for immunoglobulin kappa J region |
chr11_-_8892464 | 0.67 |
ENST00000527347.1
ENST00000526241.1 ENST00000526126.1 ENST00000530938.1 ENST00000526057.1 |
ST5
|
suppression of tumorigenicity 5 |
chr3_+_171844762 | 0.67 |
ENST00000443501.1
|
FNDC3B
|
fibronectin type III domain containing 3B |
chr1_+_159931002 | 0.66 |
ENST00000443364.1
ENST00000423943.1 |
RP11-48O20.4
|
long intergenic non-protein coding RNA 1133 |
chr14_-_61748550 | 0.66 |
ENST00000555868.1
|
TMEM30B
|
transmembrane protein 30B |
chr9_+_124329336 | 0.66 |
ENST00000394340.3
ENST00000436835.1 ENST00000259371.2 |
DAB2IP
|
DAB2 interacting protein |
chr1_+_86046433 | 0.66 |
ENST00000451137.2
|
CYR61
|
cysteine-rich, angiogenic inducer, 61 |
chr7_+_55177416 | 0.65 |
ENST00000450046.1
ENST00000454757.2 |
EGFR
|
epidermal growth factor receptor |
chr6_+_116691001 | 0.65 |
ENST00000537543.1
|
DSE
|
dermatan sulfate epimerase |
chr12_-_49582837 | 0.64 |
ENST00000547939.1
ENST00000546918.1 ENST00000552924.1 |
TUBA1A
|
tubulin, alpha 1a |
chr7_+_134551583 | 0.63 |
ENST00000435928.1
|
CALD1
|
caldesmon 1 |
chrX_+_105936982 | 0.63 |
ENST00000418562.1
|
RNF128
|
ring finger protein 128, E3 ubiquitin protein ligase |
chr15_-_42749711 | 0.63 |
ENST00000565611.1
ENST00000263805.4 ENST00000565948.1 |
ZNF106
|
zinc finger protein 106 |
chr18_+_61442629 | 0.63 |
ENST00000398019.2
ENST00000540675.1 |
SERPINB7
|
serpin peptidase inhibitor, clade B (ovalbumin), member 7 |
chrX_+_48367338 | 0.63 |
ENST00000359882.4
ENST00000537758.1 ENST00000367574.4 ENST00000355961.4 ENST00000489940.1 ENST00000361988.3 |
PORCN
|
porcupine homolog (Drosophila) |
chr6_-_47009996 | 0.62 |
ENST00000371243.2
|
GPR110
|
G protein-coupled receptor 110 |
chr3_-_141747950 | 0.62 |
ENST00000497579.1
|
TFDP2
|
transcription factor Dp-2 (E2F dimerization partner 2) |
chr12_+_27396901 | 0.62 |
ENST00000541191.1
ENST00000389032.3 |
STK38L
|
serine/threonine kinase 38 like |
chr1_+_38022572 | 0.62 |
ENST00000541606.1
|
DNALI1
|
dynein, axonemal, light intermediate chain 1 |
chr20_-_10654639 | 0.62 |
ENST00000254958.5
|
JAG1
|
jagged 1 |
chr11_+_128563652 | 0.61 |
ENST00000527786.2
|
FLI1
|
Fli-1 proto-oncogene, ETS transcription factor |
chr10_+_47746929 | 0.61 |
ENST00000340243.6
ENST00000374277.5 ENST00000449464.2 ENST00000538825.1 ENST00000335083.5 |
ANXA8L2
AL603965.1
|
annexin A8-like 2 Protein LOC100996760 |
chr4_-_153274078 | 0.60 |
ENST00000263981.5
|
FBXW7
|
F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase |
chr4_+_69313145 | 0.60 |
ENST00000305363.4
|
TMPRSS11E
|
transmembrane protease, serine 11E |
chr11_+_33563821 | 0.60 |
ENST00000321505.4
ENST00000265654.5 ENST00000389726.3 |
KIAA1549L
|
KIAA1549-like |
chr6_+_43739697 | 0.59 |
ENST00000230480.6
|
VEGFA
|
vascular endothelial growth factor A |
chr12_-_57037284 | 0.59 |
ENST00000551570.1
|
ATP5B
|
ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide |
chr12_-_118490403 | 0.59 |
ENST00000535496.1
|
WSB2
|
WD repeat and SOCS box containing 2 |
chr5_-_124080203 | 0.59 |
ENST00000504926.1
|
ZNF608
|
zinc finger protein 608 |
chrX_-_41782592 | 0.58 |
ENST00000378158.1
|
CASK
|
calcium/calmodulin-dependent serine protein kinase (MAGUK family) |
chr20_+_12989596 | 0.58 |
ENST00000434210.1
ENST00000399002.2 |
SPTLC3
|
serine palmitoyltransferase, long chain base subunit 3 |
chr7_-_104909435 | 0.58 |
ENST00000357311.3
|
SRPK2
|
SRSF protein kinase 2 |
chr1_-_151319318 | 0.58 |
ENST00000436271.1
ENST00000450506.1 ENST00000422595.1 |
RFX5
|
regulatory factor X, 5 (influences HLA class II expression) |
chr10_-_29923893 | 0.57 |
ENST00000355867.4
|
SVIL
|
supervillin |
chr1_-_183559693 | 0.57 |
ENST00000367535.3
ENST00000413720.1 ENST00000418089.1 |
NCF2
|
neutrophil cytosolic factor 2 |
chr11_+_131240593 | 0.57 |
ENST00000539799.1
|
NTM
|
neurotrimin |
chr5_+_138210919 | 0.57 |
ENST00000522013.1
ENST00000520260.1 ENST00000523298.1 ENST00000520865.1 ENST00000519634.1 ENST00000517533.1 ENST00000523685.1 ENST00000519768.1 ENST00000517656.1 ENST00000521683.1 ENST00000521640.1 ENST00000519116.1 |
CTNNA1
|
catenin (cadherin-associated protein), alpha 1, 102kDa |
chr14_+_32546145 | 0.57 |
ENST00000556611.1
ENST00000539826.2 |
ARHGAP5
|
Rho GTPase activating protein 5 |
chr12_+_51318513 | 0.57 |
ENST00000332160.4
|
METTL7A
|
methyltransferase like 7A |
chr15_+_96869165 | 0.57 |
ENST00000421109.2
|
NR2F2
|
nuclear receptor subfamily 2, group F, member 2 |
chr16_+_57679859 | 0.56 |
ENST00000569494.1
ENST00000566169.1 |
GPR56
|
G protein-coupled receptor 56 |
chr8_+_94929969 | 0.56 |
ENST00000517764.1
|
PDP1
|
pyruvate dehyrogenase phosphatase catalytic subunit 1 |
chr1_-_68698197 | 0.56 |
ENST00000370973.2
ENST00000370971.1 |
WLS
|
wntless Wnt ligand secretion mediator |
chr2_-_230787879 | 0.56 |
ENST00000435716.1
|
TRIP12
|
thyroid hormone receptor interactor 12 |
chrX_+_100663243 | 0.56 |
ENST00000316594.5
|
HNRNPH2
|
heterogeneous nuclear ribonucleoprotein H2 (H') |
chr15_-_34629922 | 0.56 |
ENST00000559484.1
ENST00000354181.3 ENST00000558589.1 ENST00000458406.2 |
SLC12A6
|
solute carrier family 12 (potassium/chloride transporter), member 6 |
chr10_+_111967345 | 0.55 |
ENST00000332674.5
ENST00000453116.1 |
MXI1
|
MAX interactor 1, dimerization protein |
chr12_+_96588368 | 0.55 |
ENST00000547860.1
|
ELK3
|
ELK3, ETS-domain protein (SRF accessory protein 2) |
chr8_-_13134246 | 0.55 |
ENST00000503161.2
|
DLC1
|
deleted in liver cancer 1 |
chr11_-_57089671 | 0.55 |
ENST00000532437.1
|
TNKS1BP1
|
tankyrase 1 binding protein 1, 182kDa |
chr21_-_35899113 | 0.55 |
ENST00000492600.1
ENST00000481448.1 ENST00000381132.2 |
RCAN1
|
regulator of calcineurin 1 |
chr1_-_160990886 | 0.55 |
ENST00000537746.1
|
F11R
|
F11 receptor |
chr1_+_24646263 | 0.55 |
ENST00000524724.1
|
GRHL3
|
grainyhead-like 3 (Drosophila) |
chr6_-_56716686 | 0.54 |
ENST00000520645.1
|
DST
|
dystonin |
chr11_+_13299186 | 0.54 |
ENST00000527998.1
ENST00000396441.3 ENST00000533520.1 ENST00000529825.1 ENST00000389707.4 ENST00000401424.1 ENST00000529388.1 ENST00000530357.1 ENST00000403290.1 ENST00000361003.4 ENST00000389708.3 ENST00000403510.3 ENST00000482049.1 |
ARNTL
|
aryl hydrocarbon receptor nuclear translocator-like |
chrX_+_102585124 | 0.54 |
ENST00000332431.4
ENST00000372666.1 |
TCEAL7
|
transcription elongation factor A (SII)-like 7 |
chr11_+_86502085 | 0.54 |
ENST00000527521.1
|
PRSS23
|
protease, serine, 23 |
chr1_-_115053781 | 0.54 |
ENST00000358465.2
ENST00000369543.2 |
TRIM33
|
tripartite motif containing 33 |
chr9_-_13165457 | 0.53 |
ENST00000542239.1
ENST00000538841.1 ENST00000433359.2 |
MPDZ
|
multiple PDZ domain protein |
chr11_+_19799327 | 0.53 |
ENST00000540292.1
|
NAV2
|
neuron navigator 2 |
chr8_-_13134045 | 0.52 |
ENST00000512044.2
|
DLC1
|
deleted in liver cancer 1 |
chr14_-_36988882 | 0.52 |
ENST00000498187.2
|
NKX2-1
|
NK2 homeobox 1 |
chr3_-_56809685 | 0.52 |
ENST00000413728.2
|
ARHGEF3
|
Rho guanine nucleotide exchange factor (GEF) 3 |
chr1_+_24646002 | 0.52 |
ENST00000356046.2
|
GRHL3
|
grainyhead-like 3 (Drosophila) |
chr1_+_61547405 | 0.51 |
ENST00000371189.4
|
NFIA
|
nuclear factor I/A |
chr3_-_25706368 | 0.51 |
ENST00000424225.1
|
TOP2B
|
topoisomerase (DNA) II beta 180kDa |
chr4_-_143226979 | 0.51 |
ENST00000514525.1
|
INPP4B
|
inositol polyphosphate-4-phosphatase, type II, 105kDa |
chr20_-_57089934 | 0.50 |
ENST00000439429.1
ENST00000371149.3 |
APCDD1L
|
adenomatosis polyposis coli down-regulated 1-like |
chr1_+_174846570 | 0.50 |
ENST00000392064.2
|
RABGAP1L
|
RAB GTPase activating protein 1-like |
chr6_-_75912508 | 0.50 |
ENST00000416123.2
|
COL12A1
|
collagen, type XII, alpha 1 |
chr3_+_127770455 | 0.50 |
ENST00000464451.1
|
SEC61A1
|
Sec61 alpha 1 subunit (S. cerevisiae) |
chr20_-_36156125 | 0.50 |
ENST00000397135.1
ENST00000397137.1 |
BLCAP
|
bladder cancer associated protein |
chr2_+_191334212 | 0.49 |
ENST00000444317.1
ENST00000535751.1 |
MFSD6
|
major facilitator superfamily domain containing 6 |
chr5_+_96211643 | 0.49 |
ENST00000437043.3
ENST00000510373.1 |
ERAP2
|
endoplasmic reticulum aminopeptidase 2 |
chr1_+_26605618 | 0.49 |
ENST00000270792.5
|
SH3BGRL3
|
SH3 domain binding glutamic acid-rich protein like 3 |
chr12_+_112563335 | 0.49 |
ENST00000549358.1
ENST00000257604.5 ENST00000548092.1 ENST00000552896.1 |
TRAFD1
|
TRAF-type zinc finger domain containing 1 |
chr15_+_43985725 | 0.48 |
ENST00000413453.2
|
CKMT1A
|
creatine kinase, mitochondrial 1A |
chr3_-_111852061 | 0.48 |
ENST00000488580.1
ENST00000460387.2 ENST00000484193.1 ENST00000487901.1 |
GCSAM
|
germinal center-associated, signaling and motility |
chr11_+_58938903 | 0.48 |
ENST00000532982.1
|
DTX4
|
deltex homolog 4 (Drosophila) |
chr11_+_123986069 | 0.48 |
ENST00000456829.2
ENST00000361352.5 ENST00000449321.1 ENST00000392748.1 ENST00000360334.4 ENST00000392744.4 |
VWA5A
|
von Willebrand factor A domain containing 5A |
chr10_-_105615164 | 0.48 |
ENST00000355946.2
ENST00000369774.4 |
SH3PXD2A
|
SH3 and PX domains 2A |
chr8_+_55466915 | 0.48 |
ENST00000522711.2
|
RP11-53M11.3
|
RP11-53M11.3 |
chr18_-_47376197 | 0.47 |
ENST00000592688.1
|
MYO5B
|
myosin VB |
chr11_-_46113756 | 0.47 |
ENST00000531959.1
|
PHF21A
|
PHD finger protein 21A |
chr8_+_38854368 | 0.47 |
ENST00000466936.1
|
ADAM9
|
ADAM metallopeptidase domain 9 |
chr16_+_57679945 | 0.47 |
ENST00000568157.1
|
GPR56
|
G protein-coupled receptor 56 |
chr3_+_9944492 | 0.47 |
ENST00000383814.3
ENST00000454190.2 ENST00000454992.1 |
IL17RE
|
interleukin 17 receptor E |
chr13_+_97928395 | 0.47 |
ENST00000445661.2
|
MBNL2
|
muscleblind-like splicing regulator 2 |
chr15_-_41694640 | 0.46 |
ENST00000558719.1
ENST00000260361.4 ENST00000560978.1 |
NDUFAF1
|
NADH dehydrogenase (ubiquinone) complex I, assembly factor 1 |
chr5_-_124082279 | 0.46 |
ENST00000513986.1
|
ZNF608
|
zinc finger protein 608 |
chrX_-_30993201 | 0.46 |
ENST00000288422.2
ENST00000378932.2 |
TAB3
|
TGF-beta activated kinase 1/MAP3K7 binding protein 3 |
chr14_-_54955376 | 0.46 |
ENST00000553333.1
|
GMFB
|
glia maturation factor, beta |
chr5_-_42811986 | 0.46 |
ENST00000511224.1
ENST00000507920.1 ENST00000510965.1 |
SEPP1
|
selenoprotein P, plasma, 1 |
chr1_+_151512775 | 0.46 |
ENST00000368849.3
ENST00000392712.3 ENST00000353024.3 ENST00000368848.2 ENST00000538902.1 |
TUFT1
|
tuftelin 1 |
chr11_+_35211429 | 0.46 |
ENST00000525688.1
ENST00000278385.6 ENST00000533222.1 |
CD44
|
CD44 molecule (Indian blood group) |
chr6_-_11779403 | 0.46 |
ENST00000414691.3
|
ADTRP
|
androgen-dependent TFPI-regulating protein |
chr7_-_107204337 | 0.46 |
ENST00000605888.1
ENST00000347053.3 |
COG5
|
component of oligomeric golgi complex 5 |
chr2_-_134326009 | 0.45 |
ENST00000409261.1
ENST00000409213.1 |
NCKAP5
|
NCK-associated protein 5 |
chr10_-_27149851 | 0.45 |
ENST00000376142.2
ENST00000359188.4 ENST00000376139.2 ENST00000376160.1 |
ABI1
|
abl-interactor 1 |
chr14_+_62164340 | 0.45 |
ENST00000557538.1
ENST00000539097.1 |
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
chrX_+_105937068 | 0.45 |
ENST00000324342.3
|
RNF128
|
ring finger protein 128, E3 ubiquitin protein ligase |
chr8_-_11710979 | 0.45 |
ENST00000415599.2
|
CTSB
|
cathepsin B |
chr8_+_42873548 | 0.44 |
ENST00000533338.1
ENST00000534420.1 |
HOOK3
RP11-598P20.5
|
hook microtubule-tethering protein 3 Uncharacterized protein |
chr12_-_76425368 | 0.44 |
ENST00000602540.1
|
PHLDA1
|
pleckstrin homology-like domain, family A, member 1 |
chr1_+_24645915 | 0.44 |
ENST00000350501.5
|
GRHL3
|
grainyhead-like 3 (Drosophila) |
chr9_+_115913222 | 0.44 |
ENST00000259392.3
|
SLC31A2
|
solute carrier family 31 (copper transporter), member 2 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 2.6 | GO:1902362 | melanocyte apoptotic process(GO:1902362) |
0.7 | 2.2 | GO:0060279 | regulation of ovulation(GO:0060278) positive regulation of ovulation(GO:0060279) |
0.6 | 1.3 | GO:0048565 | digestive tract development(GO:0048565) |
0.6 | 1.8 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
0.6 | 1.7 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.4 | 1.7 | GO:0007206 | phospholipase C-activating G-protein coupled glutamate receptor signaling pathway(GO:0007206) |
0.3 | 1.0 | GO:0034148 | regulation of toll-like receptor 5 signaling pathway(GO:0034147) negative regulation of toll-like receptor 5 signaling pathway(GO:0034148) negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070429) tolerance induction to lipopolysaccharide(GO:0072573) negative regulation of CD40 signaling pathway(GO:2000349) |
0.3 | 2.4 | GO:1901297 | positive regulation of ephrin receptor signaling pathway(GO:1901189) positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:1901297) positive regulation of canonical Wnt signaling pathway involved in heart development(GO:1905068) |
0.3 | 1.2 | GO:0035627 | ceramide transport(GO:0035627) |
0.3 | 1.8 | GO:0072619 | interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
0.3 | 1.1 | GO:0010430 | fatty acid omega-oxidation(GO:0010430) |
0.2 | 1.7 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.2 | 0.7 | GO:1990654 | sebum secreting cell proliferation(GO:1990654) |
0.2 | 1.0 | GO:0061357 | positive regulation of Wnt protein secretion(GO:0061357) |
0.2 | 0.7 | GO:0001172 | transcription, RNA-templated(GO:0001172) |
0.2 | 0.7 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.2 | 3.5 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.2 | 0.8 | GO:0090096 | regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
0.2 | 0.6 | GO:1903570 | regulation of protein kinase D signaling(GO:1903570) positive regulation of protein kinase D signaling(GO:1903572) |
0.2 | 1.7 | GO:0051549 | positive regulation of keratinocyte migration(GO:0051549) |
0.2 | 1.1 | GO:0097021 | lymphocyte migration into lymphoid organs(GO:0097021) |
0.2 | 0.9 | GO:2000638 | regulation of SREBP signaling pathway(GO:2000638) negative regulation of SREBP signaling pathway(GO:2000639) |
0.2 | 1.6 | GO:0035494 | SNARE complex disassembly(GO:0035494) |
0.2 | 2.9 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.2 | 0.3 | GO:0042733 | embryonic digit morphogenesis(GO:0042733) |
0.2 | 1.1 | GO:0032468 | Golgi calcium ion homeostasis(GO:0032468) |
0.2 | 0.6 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.2 | 0.9 | GO:1904383 | response to sodium phosphate(GO:1904383) |
0.1 | 0.4 | GO:0061419 | positive regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061419) |
0.1 | 0.4 | GO:0045210 | FasL biosynthetic process(GO:0045210) |
0.1 | 0.7 | GO:0003409 | optic cup structural organization(GO:0003409) oculomotor nerve morphogenesis(GO:0021622) oculomotor nerve formation(GO:0021623) |
0.1 | 0.7 | GO:0046086 | adenosine biosynthetic process(GO:0046086) |
0.1 | 0.6 | GO:0009956 | radial pattern formation(GO:0009956) |
0.1 | 0.4 | GO:1990051 | activation of protein kinase C activity(GO:1990051) |
0.1 | 0.7 | GO:0060005 | vestibular reflex(GO:0060005) |
0.1 | 0.7 | GO:1903906 | plasma membrane raft distribution(GO:0044855) plasma membrane raft localization(GO:0044856) plasma membrane raft polarization(GO:0044858) regulation of plasma membrane raft polarization(GO:1903906) |
0.1 | 1.5 | GO:0070487 | monocyte aggregation(GO:0070487) |
0.1 | 0.7 | GO:0043553 | vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.1 | 0.9 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
0.1 | 2.1 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.1 | 0.6 | GO:0090362 | positive regulation of platelet-derived growth factor production(GO:0090362) |
0.1 | 1.5 | GO:0061042 | vascular wound healing(GO:0061042) |
0.1 | 0.5 | GO:2000298 | regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
0.1 | 1.0 | GO:0033590 | response to cobalamin(GO:0033590) |
0.1 | 1.0 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.1 | 0.4 | GO:0010160 | sensory organ boundary specification(GO:0008052) formation of organ boundary(GO:0010160) taste bud development(GO:0061193) |
0.1 | 0.4 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
0.1 | 0.6 | GO:2001045 | negative regulation of integrin-mediated signaling pathway(GO:2001045) |
0.1 | 0.3 | GO:0035508 | positive regulation of myosin-light-chain-phosphatase activity(GO:0035508) |
0.1 | 0.6 | GO:0071477 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
0.1 | 0.5 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.1 | 0.6 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
0.1 | 0.7 | GO:1902951 | negative regulation of dendritic spine maintenance(GO:1902951) |
0.1 | 0.8 | GO:1903826 | arginine transmembrane transport(GO:1903826) |
0.1 | 0.3 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
0.1 | 2.3 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.1 | 0.6 | GO:0035063 | nuclear speck organization(GO:0035063) |
0.1 | 0.4 | GO:0060151 | peroxisome localization(GO:0060151) microtubule-based peroxisome localization(GO:0060152) |
0.1 | 0.5 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
0.1 | 0.4 | GO:0036228 | protein targeting to nuclear inner membrane(GO:0036228) |
0.1 | 1.0 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.1 | 0.8 | GO:0021564 | regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) vagus nerve development(GO:0021564) |
0.1 | 0.3 | GO:0090472 | viral protein processing(GO:0019082) regulation of nerve growth factor production(GO:0032903) negative regulation of nerve growth factor production(GO:0032904) dibasic protein processing(GO:0090472) |
0.1 | 0.3 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.1 | 1.4 | GO:0060242 | contact inhibition(GO:0060242) |
0.1 | 0.5 | GO:0061034 | olfactory bulb mitral cell layer development(GO:0061034) |
0.1 | 0.2 | GO:0021722 | superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
0.1 | 0.3 | GO:0023016 | signal transduction by trans-phosphorylation(GO:0023016) |
0.1 | 0.7 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.1 | 0.5 | GO:1903786 | mycotoxin catabolic process(GO:0043387) aflatoxin catabolic process(GO:0046223) organic heteropentacyclic compound catabolic process(GO:1901377) regulation of glutathione biosynthetic process(GO:1903786) positive regulation of glutathione biosynthetic process(GO:1903788) |
0.1 | 0.4 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.1 | 1.1 | GO:1904352 | positive regulation of protein catabolic process in the vacuole(GO:1904352) |
0.1 | 0.3 | GO:0009236 | cobalamin biosynthetic process(GO:0009236) |
0.1 | 2.5 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.1 | 0.4 | GO:0035947 | regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter(GO:0035947) |
0.1 | 1.4 | GO:0014894 | response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.1 | 5.4 | GO:0030835 | negative regulation of actin filament depolymerization(GO:0030835) |
0.1 | 0.3 | GO:0042144 | vacuole fusion, non-autophagic(GO:0042144) |
0.1 | 0.3 | GO:0046338 | phosphatidylethanolamine catabolic process(GO:0046338) |
0.1 | 0.2 | GO:0046901 | tetrahydrofolylpolyglutamate biosynthetic process(GO:0046901) |
0.1 | 0.6 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.1 | 0.2 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
0.1 | 0.3 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.1 | 0.1 | GO:0016241 | regulation of macroautophagy(GO:0016241) |
0.1 | 0.5 | GO:0072674 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
0.1 | 0.3 | GO:0021816 | lamellipodium assembly involved in ameboidal cell migration(GO:0003363) extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration(GO:0021816) |
0.1 | 1.1 | GO:0046520 | sphingoid biosynthetic process(GO:0046520) |
0.1 | 0.6 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.1 | 0.4 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.1 | 0.8 | GO:2000576 | positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
0.1 | 1.1 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.1 | 0.5 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.1 | 0.2 | GO:0072209 | metanephric mesangial cell differentiation(GO:0072209) metanephric glomerular mesangial cell differentiation(GO:0072254) metanephric glomerular mesangial cell development(GO:0072255) reversible differentiation(GO:0090677) cell dedifferentiation involved in phenotypic switching(GO:0090678) positive regulation of phenotypic switching(GO:1900241) regulation of vascular smooth muscle cell dedifferentiation(GO:1905174) positive regulation of vascular smooth muscle cell dedifferentiation(GO:1905176) vascular smooth muscle cell dedifferentiation(GO:1990936) |
0.1 | 0.5 | GO:1902730 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition(GO:0044334) myoblast fate commitment(GO:0048625) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.1 | 0.4 | GO:0051012 | microtubule sliding(GO:0051012) |
0.1 | 0.5 | GO:0032439 | endosome localization(GO:0032439) |
0.1 | 0.6 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.1 | 0.5 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
0.1 | 1.0 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.1 | 1.5 | GO:0060004 | reflex(GO:0060004) |
0.1 | 0.6 | GO:1901315 | negative regulation of histone ubiquitination(GO:0033183) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) |
0.1 | 0.4 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.1 | 0.2 | GO:2000364 | regulation of STAT protein import into nucleus(GO:2000364) positive regulation of STAT protein import into nucleus(GO:2000366) |
0.1 | 0.6 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
0.1 | 0.4 | GO:0019075 | virus maturation(GO:0019075) |
0.1 | 0.6 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.1 | 0.2 | GO:1904924 | negative regulation of mitophagy in response to mitochondrial depolarization(GO:1904924) |
0.1 | 0.4 | GO:1900044 | regulation of protein K63-linked ubiquitination(GO:1900044) |
0.1 | 0.5 | GO:0097396 | response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
0.1 | 0.3 | GO:0033489 | cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
0.1 | 0.7 | GO:0060056 | mammary gland involution(GO:0060056) |
0.1 | 0.3 | GO:1990169 | detoxification of copper ion(GO:0010273) cellular response to erythropoietin(GO:0036018) stress response to copper ion(GO:1990169) |
0.1 | 0.2 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.1 | 0.2 | GO:0034164 | negative regulation of toll-like receptor 9 signaling pathway(GO:0034164) |
0.0 | 0.2 | GO:1902904 | negative regulation of fibril organization(GO:1902904) chaperone-mediated autophagy translocation complex disassembly(GO:1904764) |
0.0 | 0.3 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.0 | 0.5 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
0.0 | 0.1 | GO:1903033 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
0.0 | 0.7 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.0 | 0.5 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.0 | 0.9 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.0 | 0.2 | GO:0042823 | pyridoxal phosphate biosynthetic process(GO:0042823) |
0.0 | 0.6 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.0 | 0.5 | GO:0021759 | globus pallidus development(GO:0021759) |
0.0 | 0.2 | GO:0043335 | protein unfolding(GO:0043335) |
0.0 | 0.2 | GO:0034334 | adherens junction maintenance(GO:0034334) |
0.0 | 0.6 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.0 | 0.2 | GO:0007296 | vitellogenesis(GO:0007296) |
0.0 | 0.2 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
0.0 | 0.4 | GO:0002159 | desmosome assembly(GO:0002159) |
0.0 | 0.5 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.0 | 0.3 | GO:0052696 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
0.0 | 0.1 | GO:0042704 | detection of oxygen(GO:0003032) uterine wall breakdown(GO:0042704) |
0.0 | 0.2 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.0 | 0.3 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
0.0 | 0.2 | GO:0034959 | substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
0.0 | 0.2 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
0.0 | 1.5 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
0.0 | 0.5 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.0 | 0.4 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.0 | 0.2 | GO:1900147 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
0.0 | 0.2 | GO:0019918 | peptidyl-arginine methylation, to symmetrical-dimethyl arginine(GO:0019918) |
0.0 | 0.5 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.0 | 0.2 | GO:0032185 | septin cytoskeleton organization(GO:0032185) |
0.0 | 0.5 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.0 | 0.3 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.0 | 0.2 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
0.0 | 0.6 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.0 | 0.1 | GO:1990737 | response to manganese-induced endoplasmic reticulum stress(GO:1990737) |
0.0 | 0.5 | GO:0030834 | regulation of actin filament depolymerization(GO:0030834) |
0.0 | 0.5 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
0.0 | 0.2 | GO:0034093 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.0 | 0.4 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.0 | 0.4 | GO:0060174 | limb bud formation(GO:0060174) |
0.0 | 1.0 | GO:0015695 | organic cation transport(GO:0015695) |
0.0 | 0.6 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
0.0 | 0.2 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.0 | 0.2 | GO:0072660 | positive regulation of cell communication by electrical coupling(GO:0010650) maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
0.0 | 0.2 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
0.0 | 0.3 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
0.0 | 0.9 | GO:0060074 | synapse maturation(GO:0060074) |
0.0 | 0.1 | GO:1904020 | regulation of G-protein coupled receptor internalization(GO:1904020) |
0.0 | 0.4 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
0.0 | 0.3 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.0 | 0.2 | GO:2000490 | negative regulation of hepatic stellate cell activation(GO:2000490) |
0.0 | 4.3 | GO:0070268 | cornification(GO:0070268) |
0.0 | 0.3 | GO:1904885 | beta-catenin destruction complex assembly(GO:1904885) |
0.0 | 0.5 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.0 | 0.6 | GO:0046697 | decidualization(GO:0046697) |
0.0 | 0.2 | GO:0072734 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
0.0 | 0.5 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.0 | 0.2 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.0 | 0.0 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.0 | 0.1 | GO:0007619 | courtship behavior(GO:0007619) female courtship behavior(GO:0008050) |
0.0 | 0.1 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.0 | 0.3 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.0 | 0.3 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.0 | 0.2 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.0 | 0.1 | GO:0051708 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
0.0 | 0.2 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.0 | 0.3 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.0 | 0.2 | GO:0001781 | neutrophil apoptotic process(GO:0001781) |
0.0 | 0.3 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.0 | 1.3 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.0 | 0.4 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.0 | 0.1 | GO:0044501 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
0.0 | 0.2 | GO:1904220 | regulation of serine C-palmitoyltransferase activity(GO:1904220) |
0.0 | 0.2 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.0 | 0.3 | GO:0009249 | protein lipoylation(GO:0009249) |
0.0 | 0.8 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.0 | 0.1 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.0 | 0.2 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.0 | 0.2 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.0 | 0.2 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.0 | 0.2 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
0.0 | 0.2 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.0 | 0.2 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
0.0 | 1.2 | GO:0008038 | neuron recognition(GO:0008038) |
0.0 | 0.1 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
0.0 | 0.3 | GO:1902166 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
0.0 | 1.8 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.0 | 0.3 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.0 | 0.1 | GO:0015788 | UDP-N-acetylglucosamine transport(GO:0015788) UDP-N-acetylglucosamine transmembrane transport(GO:1990569) |
0.0 | 0.2 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.0 | 0.6 | GO:0042994 | cytoplasmic sequestering of transcription factor(GO:0042994) |
0.0 | 0.3 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.0 | 0.1 | GO:2000394 | positive regulation of lamellipodium morphogenesis(GO:2000394) |
0.0 | 0.3 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
0.0 | 1.6 | GO:0032508 | DNA duplex unwinding(GO:0032508) |
0.0 | 0.1 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
0.0 | 0.2 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
0.0 | 0.4 | GO:0009642 | response to light intensity(GO:0009642) |
0.0 | 0.2 | GO:0072718 | response to cisplatin(GO:0072718) |
0.0 | 0.6 | GO:0045730 | respiratory burst(GO:0045730) |
0.0 | 0.2 | GO:0043392 | negative regulation of DNA binding(GO:0043392) |
0.0 | 0.6 | GO:0015012 | heparan sulfate proteoglycan biosynthetic process(GO:0015012) |
0.0 | 0.6 | GO:0051894 | positive regulation of focal adhesion assembly(GO:0051894) positive regulation of adherens junction organization(GO:1903393) |
0.0 | 0.3 | GO:0006338 | chromatin remodeling(GO:0006338) |
0.0 | 0.2 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.0 | 0.2 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.0 | 0.1 | GO:0070836 | caveola assembly(GO:0070836) |
0.0 | 0.1 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.0 | 0.3 | GO:0003334 | keratinocyte development(GO:0003334) |
0.0 | 0.3 | GO:0048569 | post-embryonic organ development(GO:0048569) |
0.0 | 0.1 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.0 | 0.1 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
0.0 | 1.8 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
0.0 | 0.1 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.0 | 0.1 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.0 | 0.1 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
0.0 | 0.1 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
0.0 | 0.3 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.0 | 0.6 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.0 | 0.7 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.0 | 0.1 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.0 | 0.1 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.0 | 0.6 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.0 | 0.0 | GO:0035502 | metanephric part of ureteric bud development(GO:0035502) |
0.0 | 0.1 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.0 | 0.1 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) |
0.0 | 0.4 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.0 | 1.7 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.0 | 0.3 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.0 | 0.7 | GO:0061512 | protein localization to cilium(GO:0061512) |
0.0 | 0.6 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.0 | 0.5 | GO:0030514 | negative regulation of BMP signaling pathway(GO:0030514) |
0.0 | 0.3 | GO:0061157 | mRNA destabilization(GO:0061157) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 2.2 | GO:0043512 | inhibin complex(GO:0043511) inhibin A complex(GO:0043512) |
0.3 | 1.4 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
0.2 | 2.4 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.2 | 0.7 | GO:1990032 | parallel fiber(GO:1990032) |
0.2 | 0.6 | GO:0097489 | multivesicular body, internal vesicle lumen(GO:0097489) |
0.2 | 0.7 | GO:0005889 | hydrogen:potassium-exchanging ATPase complex(GO:0005889) |
0.2 | 1.8 | GO:0098645 | network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) |
0.2 | 1.2 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.2 | 0.5 | GO:0005595 | collagen type XII trimer(GO:0005595) |
0.2 | 0.6 | GO:0031592 | centrosomal corona(GO:0031592) |
0.1 | 2.2 | GO:0045180 | basal cortex(GO:0045180) |
0.1 | 2.6 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.1 | 0.9 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
0.1 | 0.3 | GO:0035525 | NF-kappaB p50/p65 complex(GO:0035525) |
0.1 | 3.3 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 1.3 | GO:0017059 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.1 | 0.4 | GO:0019867 | outer membrane(GO:0019867) |
0.1 | 0.4 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.1 | 0.5 | GO:0031673 | H zone(GO:0031673) |
0.1 | 1.3 | GO:0030478 | actin cap(GO:0030478) |
0.1 | 0.6 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) |
0.1 | 0.2 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.1 | 3.3 | GO:0030057 | desmosome(GO:0030057) |
0.1 | 1.4 | GO:0070938 | contractile ring(GO:0070938) |
0.1 | 0.3 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.1 | 1.2 | GO:0031209 | SCAR complex(GO:0031209) |
0.1 | 0.3 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.1 | 0.5 | GO:0031415 | NatA complex(GO:0031415) |
0.1 | 0.5 | GO:0071664 | beta-catenin-TCF7L2 complex(GO:0070369) catenin-TCF7L2 complex(GO:0071664) |
0.1 | 0.7 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.1 | 0.6 | GO:0032010 | phagolysosome(GO:0032010) |
0.1 | 0.5 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
0.1 | 0.9 | GO:0012505 | endomembrane system(GO:0012505) |
0.1 | 6.1 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.1 | 0.4 | GO:0070695 | FHF complex(GO:0070695) |
0.1 | 0.5 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.1 | 0.7 | GO:0016342 | catenin complex(GO:0016342) |
0.0 | 1.5 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.0 | 1.2 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.0 | 0.1 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.0 | 0.2 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.0 | 0.1 | GO:0043614 | multi-eIF complex(GO:0043614) translation preinitiation complex(GO:0070993) glial limiting end-foot(GO:0097451) |
0.0 | 1.0 | GO:0000974 | Prp19 complex(GO:0000974) |
0.0 | 0.1 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.0 | 0.3 | GO:1990635 | proximal dendrite(GO:1990635) |
0.0 | 0.5 | GO:0045179 | apical cortex(GO:0045179) |
0.0 | 0.4 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.0 | 0.2 | GO:0031302 | intrinsic component of endosome membrane(GO:0031302) |
0.0 | 1.3 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.0 | 0.2 | GO:0036021 | endolysosome lumen(GO:0036021) |
0.0 | 1.9 | GO:0043034 | costamere(GO:0043034) |
0.0 | 0.1 | GO:0000346 | transcription export complex(GO:0000346) |
0.0 | 0.5 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.0 | 0.5 | GO:0033391 | chromatoid body(GO:0033391) |
0.0 | 0.1 | GO:0000333 | telomerase catalytic core complex(GO:0000333) |
0.0 | 0.3 | GO:0033263 | CORVET complex(GO:0033263) |
0.0 | 1.0 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.0 | 0.1 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.0 | 0.8 | GO:0034706 | sodium channel complex(GO:0034706) |
0.0 | 2.0 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.0 | 1.1 | GO:0030286 | dynein complex(GO:0030286) |
0.0 | 0.5 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.0 | 0.4 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.0 | 0.2 | GO:0035061 | interchromatin granule(GO:0035061) |
0.0 | 0.2 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.0 | 0.4 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.0 | 1.7 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.0 | 0.3 | GO:0044327 | dendritic spine head(GO:0044327) |
0.0 | 0.5 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
0.0 | 0.3 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.0 | 0.2 | GO:0032584 | growth cone membrane(GO:0032584) |
0.0 | 1.2 | GO:0002102 | podosome(GO:0002102) |
0.0 | 3.3 | GO:0016363 | nuclear matrix(GO:0016363) |
0.0 | 1.6 | GO:0043198 | dendritic shaft(GO:0043198) |
0.0 | 0.3 | GO:0032433 | filopodium tip(GO:0032433) |
0.0 | 0.3 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.0 | 0.7 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.0 | 0.1 | GO:1902560 | GMP reductase complex(GO:1902560) |
0.0 | 0.1 | GO:0042585 | germinal vesicle(GO:0042585) |
0.0 | 0.1 | GO:0071203 | WASH complex(GO:0071203) |
0.0 | 0.4 | GO:0043197 | dendritic spine(GO:0043197) neuron spine(GO:0044309) |
0.0 | 0.1 | GO:0002169 | 3-methylcrotonyl-CoA carboxylase complex, mitochondrial(GO:0002169) methylcrotonoyl-CoA carboxylase complex(GO:1905202) |
0.0 | 1.1 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 0.2 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.0 | 0.2 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.0 | 0.2 | GO:0032039 | integrator complex(GO:0032039) |
0.0 | 0.1 | GO:0097427 | microtubule bundle(GO:0097427) |
0.0 | 0.1 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.0 | 0.2 | GO:0034709 | methylosome(GO:0034709) |
0.0 | 0.1 | GO:0031417 | NatC complex(GO:0031417) |
0.0 | 1.4 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.2 | GO:1990752 | microtubule end(GO:1990752) |
0.0 | 0.2 | GO:0008091 | spectrin(GO:0008091) |
0.0 | 0.2 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 2.2 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.3 | 1.4 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.3 | 1.2 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.3 | 1.2 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.3 | 1.1 | GO:0004031 | aldehyde oxidase activity(GO:0004031) |
0.3 | 1.8 | GO:0017050 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
0.2 | 0.7 | GO:0003968 | RNA-directed RNA polymerase activity(GO:0003968) |
0.2 | 2.1 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.2 | 0.6 | GO:1990698 | palmitoleoyltransferase activity(GO:1990698) |
0.2 | 0.7 | GO:0034602 | oxoglutarate dehydrogenase (NAD+) activity(GO:0034602) |
0.2 | 3.9 | GO:0019841 | retinol binding(GO:0019841) |
0.2 | 0.5 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.2 | 1.3 | GO:0016454 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.1 | 1.6 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.1 | 0.8 | GO:0004882 | androgen receptor activity(GO:0004882) |
0.1 | 0.6 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.1 | 0.6 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
0.1 | 2.4 | GO:0000150 | recombinase activity(GO:0000150) |
0.1 | 0.4 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.1 | 0.9 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.1 | 1.5 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.1 | 2.4 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.1 | 0.7 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.1 | 1.5 | GO:0045159 | myosin II binding(GO:0045159) |
0.1 | 1.0 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.1 | 0.8 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) |
0.1 | 0.5 | GO:0030345 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.1 | 2.1 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.1 | 1.8 | GO:0001087 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
0.1 | 5.3 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 0.4 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.1 | 2.6 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.1 | 0.6 | GO:0043532 | angiostatin binding(GO:0043532) |
0.1 | 0.5 | GO:0017161 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) inositol-1,3,4-trisphosphate 4-phosphatase activity(GO:0017161) inositol-3,4-bisphosphate 4-phosphatase activity(GO:0052828) |
0.1 | 0.2 | GO:0016534 | cyclin-dependent protein kinase 5 activator activity(GO:0016534) |
0.1 | 0.7 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) acyl-CoA desaturase activity(GO:0016215) |
0.1 | 0.6 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.1 | 0.4 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.1 | 0.5 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.1 | 1.4 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.1 | 1.2 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.1 | 1.3 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.1 | 1.1 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.1 | 0.9 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.1 | 0.2 | GO:0004326 | tetrahydrofolylpolyglutamate synthase activity(GO:0004326) dihydrofolate synthase activity(GO:0008841) |
0.1 | 0.2 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
0.1 | 0.2 | GO:0060001 | minus-end directed microfilament motor activity(GO:0060001) |
0.1 | 0.2 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.1 | 0.3 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.1 | 0.6 | GO:0043515 | kinetochore binding(GO:0043515) |
0.1 | 0.3 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.1 | 0.2 | GO:0004108 | citrate (Si)-synthase activity(GO:0004108) citrate synthase activity(GO:0036440) |
0.1 | 1.3 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
0.1 | 0.5 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.1 | 1.1 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
0.1 | 0.2 | GO:1902271 | D3 vitamins binding(GO:1902271) |
0.1 | 0.5 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.1 | 1.0 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.1 | 1.6 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.1 | 0.5 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 0.4 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.0 | 0.2 | GO:0047888 | fatty acid peroxidase activity(GO:0047888) |
0.0 | 0.2 | GO:0033765 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.0 | 0.4 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.0 | 0.3 | GO:0003713 | transcription coactivator activity(GO:0003713) |
0.0 | 0.5 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.0 | 1.5 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.0 | 1.2 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.0 | 0.5 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
0.0 | 0.2 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
0.0 | 0.5 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.0 | 0.8 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.0 | 1.0 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.0 | 2.5 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.0 | 1.6 | GO:0001968 | fibronectin binding(GO:0001968) |
0.0 | 1.4 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.0 | 1.2 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.0 | 0.5 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
0.0 | 0.2 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.0 | 0.3 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.0 | 0.3 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
0.0 | 0.2 | GO:0003883 | CTP synthase activity(GO:0003883) |
0.0 | 0.3 | GO:0042835 | BRE binding(GO:0042835) |
0.0 | 0.2 | GO:0035243 | protein-arginine omega-N symmetric methyltransferase activity(GO:0035243) |
0.0 | 1.9 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.0 | 0.5 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.0 | 1.2 | GO:0017166 | vinculin binding(GO:0017166) |
0.0 | 1.0 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.0 | 0.8 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.0 | 0.5 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.0 | 0.9 | GO:0005112 | Notch binding(GO:0005112) |
0.0 | 0.2 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
0.0 | 0.6 | GO:0031404 | chloride ion binding(GO:0031404) |
0.0 | 0.2 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.0 | 0.3 | GO:0060002 | plus-end directed microfilament motor activity(GO:0060002) |
0.0 | 0.4 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.0 | 0.7 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.0 | 0.3 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.0 | 0.1 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.0 | 1.4 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.0 | 0.3 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.0 | 0.1 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.0 | 1.4 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.0 | 0.5 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.0 | 0.3 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.0 | 0.3 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.0 | 1.3 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.0 | 5.2 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.0 | 0.2 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.0 | 0.1 | GO:0015432 | bile acid-exporting ATPase activity(GO:0015432) |
0.0 | 0.1 | GO:0004853 | uroporphyrinogen decarboxylase activity(GO:0004853) |
0.0 | 0.1 | GO:1990254 | keratin filament binding(GO:1990254) |
0.0 | 1.4 | GO:0050699 | WW domain binding(GO:0050699) |
0.0 | 0.5 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.0 | 1.7 | GO:0043621 | protein self-association(GO:0043621) |
0.0 | 2.1 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.0 | 0.0 | GO:0070336 | flap-structured DNA binding(GO:0070336) |
0.0 | 0.8 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.0 | 0.4 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.0 | 0.7 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.0 | 0.1 | GO:0008281 | sulfonylurea receptor activity(GO:0008281) |
0.0 | 0.2 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.0 | 0.1 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.0 | 0.4 | GO:0008392 | arachidonic acid monooxygenase activity(GO:0008391) arachidonic acid epoxygenase activity(GO:0008392) |
0.0 | 0.5 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.0 | 1.5 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 0.4 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.0 | 0.2 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.0 | 0.1 | GO:0005462 | UDP-N-acetylglucosamine transmembrane transporter activity(GO:0005462) |
0.0 | 0.3 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.0 | 0.1 | GO:0003920 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
0.0 | 0.0 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
0.0 | 0.2 | GO:0030911 | TPR domain binding(GO:0030911) |
0.0 | 0.4 | GO:0038191 | neuropilin binding(GO:0038191) |
0.0 | 0.4 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.0 | 0.2 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.0 | 0.5 | GO:0043236 | laminin binding(GO:0043236) |
0.0 | 0.1 | GO:0004485 | methylcrotonoyl-CoA carboxylase activity(GO:0004485) |
0.0 | 0.1 | GO:0035473 | lipase binding(GO:0035473) |
0.0 | 0.2 | GO:0042731 | PH domain binding(GO:0042731) |
0.0 | 0.3 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.0 | 0.4 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.0 | 0.4 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.0 | 0.6 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.0 | 0.6 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.0 | 1.0 | GO:0043022 | ribosome binding(GO:0043022) |
0.0 | 0.1 | GO:0047391 | phosphodiesterase I activity(GO:0004528) alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.0 | 0.7 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.0 | 0.5 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.0 | 1.1 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.0 | 0.9 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.0 | 0.6 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.0 | 0.3 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.0 | 0.2 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.0 | 0.3 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.0 | 0.2 | GO:1990459 | transferrin receptor binding(GO:1990459) |
0.0 | 0.4 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.0 | 0.0 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.0 | 0.6 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.0 | 0.5 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.0 | 1.2 | GO:0002039 | p53 binding(GO:0002039) |
0.0 | 0.2 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.0 | 1.2 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.0 | 0.1 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.0 | 0.0 | GO:0005499 | vitamin D binding(GO:0005499) |
0.0 | 0.0 | GO:0035939 | microsatellite binding(GO:0035939) |
0.0 | 0.4 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.0 | 0.2 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.0 | 0.2 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.0 | 0.2 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.0 | 0.3 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.0 | 0.3 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.0 | 0.5 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.0 | 0.2 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
0.0 | 0.2 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.0 | 0.1 | GO:0016403 | dimethylargininase activity(GO:0016403) |
0.0 | 0.1 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.0 | 0.7 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.0 | 0.1 | GO:0008142 | oxysterol binding(GO:0008142) |
0.0 | 0.1 | GO:0032451 | cobalamin binding(GO:0031419) demethylase activity(GO:0032451) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 8.4 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 2.7 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.0 | 2.3 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 4.9 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 3.7 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.0 | 1.8 | PID MYC PATHWAY | C-MYC pathway |
0.0 | 1.3 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 1.2 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.0 | 2.3 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.0 | 1.7 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.0 | 0.7 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 2.3 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.0 | 2.5 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.0 | 1.5 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 1.0 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.0 | 0.3 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 1.4 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.0 | 0.2 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.0 | 0.2 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.0 | 1.4 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 2.1 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.0 | 0.9 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.0 | 0.3 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.0 | 0.2 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.0 | 0.4 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.0 | 0.8 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 0.5 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 0.7 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.0 | 0.8 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.0 | 1.3 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 2.2 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.1 | 2.6 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.1 | 2.9 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.1 | 0.5 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.1 | 0.1 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.1 | 0.6 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.1 | 1.0 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.0 | 1.6 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 2.6 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 0.6 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.0 | 0.7 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.0 | 1.0 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.0 | 0.5 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.0 | 1.1 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.0 | 0.9 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.0 | 0.7 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.0 | 1.8 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.0 | 0.9 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.0 | 2.5 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.6 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.0 | 1.0 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 1.3 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.0 | 0.9 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.0 | 0.6 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.0 | 2.6 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.0 | 0.6 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.0 | 0.8 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.0 | 0.3 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.0 | 0.3 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.0 | 0.6 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.0 | 0.6 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.0 | 0.7 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.0 | 0.5 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.0 | 0.5 | REACTOME SIGNALING BY NOTCH | Genes involved in Signaling by NOTCH |
0.0 | 1.1 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 0.4 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.0 | 0.5 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.0 | 1.3 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.0 | 0.5 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.0 | 0.1 | REACTOME SHC RELATED EVENTS | Genes involved in SHC-related events |
0.0 | 0.4 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.0 | 0.5 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.0 | 0.5 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.0 | 1.1 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.0 | 0.8 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.0 | 1.6 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.0 | 0.3 | REACTOME RNA POL II PRE TRANSCRIPTION EVENTS | Genes involved in RNA Polymerase II Pre-transcription Events |
0.0 | 0.3 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.0 | 0.3 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.0 | 0.1 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.0 | 0.2 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.0 | 0.6 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.0 | 1.2 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 1.3 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.0 | 0.2 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.0 | 0.4 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.0 | 1.0 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.0 | 0.2 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.0 | 0.2 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |